Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. Among authors: hermsen i. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
Hermsen IG, Fassnacht M, Terzolo M, Houterman S, den Hartigh J, Leboulleux S, Daffara F, Berruti A, Chadarevian R, Schlumberger M, Allolio B, Haak HR, Baudin E. Hermsen IG, et al. J Clin Endocrinol Metab. 2011 Jun;96(6):1844-51. doi: 10.1210/jc.2010-2676. Epub 2011 Apr 6. J Clin Endocrinol Metab. 2011. PMID: 21470991
Response to radiation therapy in adrenocortical carcinoma.
Hermsen IG, Groenen YE, Dercksen MW, Theuws J, Haak HR. Hermsen IG, et al. J Endocrinol Invest. 2010 Nov;33(10):712-4. doi: 10.1007/BF03346675. Epub 2010 Mar 10. J Endocrinol Invest. 2010. PMID: 20220294
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network. Libé R, et al. Among authors: hermsen i. Ann Oncol. 2015 Oct;26(10):2119-25. doi: 10.1093/annonc/mdv329. Ann Oncol. 2015. PMID: 26392430 Free article.
Developing treatment for adrenocortical carcinoma.
Kerkhofs TM, Ettaieb MH, Hermsen IG, Haak HR. Kerkhofs TM, et al. Among authors: hermsen ig. Endocr Relat Cancer. 2015 Dec;22(6):R325-38. doi: 10.1530/ERC-15-0318. Epub 2015 Aug 10. Endocr Relat Cancer. 2015. PMID: 26259571 Review.
Disappearing adrenal masses.
Hermsen IG, Polak MP, Haak HR. Hermsen IG, et al. Endocrine. 2010 Oct;38(2):153-7. doi: 10.1007/s12020-010-9368-7. Epub 2010 Jul 11. Endocrine. 2010. PMID: 21046476